Position in CABR
as of Dec 31, 2025
· filed Feb 17, 2026
Position Value
$34
New position
Shares Held
40
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $1,773,009,188 across 50 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,831,652 | $571,149,579 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,958,814 | $119,239,475 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
199,426 | $118,255,627 | |
| 4 | HLN |
Haleon plc
|
10,934,228 | $109,451,619 | |
| 5 | VTRS |
Viatris Inc
|
7,259,555 | $98,076,585 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
4,357,672 | $90,465,268 | |
| 7 | LQDA |
Liquidia Corp
|
2,287,792 | $86,341,267 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,358,215 | $80,362,082 |
All Filings in CABR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $34 | 40 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||